Biohaven Pharmaceuticals, Inc.
Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.
-
New drug trial aims to slow progression of rare movement disorder
Disease control OngoingThis study is testing whether a daily medication called troriluzole can help slow the worsening of movement, balance, and speech problems in adults with inherited spinocerebellar ataxia (SCA). About 300 participants with specific types of SCA will take either troriluzole or a pla…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:41 UTC
-
New drug aims to build muscle in SMA patients
Disease control OngoingThis study is testing whether a new drug called taldefgrobep alfa can improve muscle function and strength in people with spinal muscular atrophy (SMA). The drug is given as a shot and is designed to block a protein that limits muscle growth. It is being tested in 269 people who …
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC